Literature DB >> 21707779

Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteria.

Monika Gad1, Peter Ravn, Ditte A Søborg, Karina Lund-Jensen, Arthur C Ouwehand, Simon S Jensen.   

Abstract

In this study, we have used monocyte-derived dendritic cells (DCs) to design a screening model for the selection of microorganisms with the ability to suppress DC-secreted IL-12p70, a critical cytokine for the induction of T-helper cell type 1 immune responses under inflammatory conditions. By the treatment of DCs with cocktails containing TLR agonists and proinflammatory cytokines, the cells increased the secretion of the Th1-promoting cytokine IL-12p70. Clinically used probiotics were tested for their IL-10- and IL-12p70-stimulating properties in immature DCs, and showed a dose-dependent change in the IL-10/IL-12p70 balance. Lactobacillus acidophilus NCFM(™) and the probiotic mixture VSL#3 showed a strong induction of IL-12p70, whereas Lactobacillus salivarius Ls-33 and Bifidobacterium infantis 35624 preferentially induced IL-10. Escherichia coli Nissle 1917 induced both IL-10 and IL-12p70, whereas the probiotic yeast Saccharomyces boulardii induced low levels of cytokines. When combining these microorganisms with the Th1-promoting cocktails, E. coli Nissle 1917 and B. infantis 35624 were potent suppressors of IL-12p70 secretion in an IL-10-independent manner, indicating a suppressive effect on Th1-inducing antigen-presenting cells. The present model, using cocktail-stimulated DCs with potent IL-12p70-stimulating capacity, may be used as an efficient tool to assess the anti-inflammatory properties of microorganisms for potential clinical use.
© 2011 Bioneer A/S. FEMS Immunology & Medical Microbiology © Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21707779     DOI: 10.1111/j.1574-695X.2011.00835.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  23 in total

1.  In vitro investigation of Debaryomyces hansenii strains for potential probiotic properties.

Authors:  Honeylet Sabas Ochangco; Amparo Gamero; Ida M Smith; Jeffrey E Christensen; Lene Jespersen; Nils Arneborg
Journal:  World J Microbiol Biotechnol       Date:  2016-07-18       Impact factor: 3.312

Review 2.  Microbial activation of gut dendritic cells and the control of mucosal immunity.

Authors:  Jennifer L Owen; Mansour Mohamadzadeh
Journal:  J Interferon Cytokine Res       Date:  2013-08-20       Impact factor: 2.607

Review 3.  Intestinal barrier: A gentlemen's agreement between microbiota and immunity.

Authors:  Andrea Moro Caricilli; Angela Castoldi; Niels Olsen Saraiva Câmara
Journal:  World J Gastrointest Pathophysiol       Date:  2014-02-15

Review 4.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  CRISPR-based curing and analysis of metabolic burden of cryptic plasmids in Escherichia coli Nissle 1917.

Authors:  Halimatun S Zainuddin; Yanfen Bai; Thomas J Mansell
Journal:  Eng Life Sci       Date:  2019-06-03       Impact factor: 2.678

6.  Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses.

Authors:  Anastasia N Vlasova; Lulu Shao; Sukumar Kandasamy; David D Fischer; Abdul Rauf; Stephanie N Langel; Kuldeep S Chattha; Anand Kumar; Huang-Chi Huang; Gireesh Rajashekara; Linda J Saif
Journal:  Eur J Immunol       Date:  2016-08-11       Impact factor: 5.532

7.  Protective effects of Lactobacillus plantarum NDC 75017 against lipopolysaccharide-induced liver injury in mice.

Authors:  Xinyan Peng; Yujun Jiang
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

8.  Bifidobacterium dentium-derived y-glutamylcysteine suppresses ER-mediated goblet cell stress and reduces TNBS-driven colonic inflammation.

Authors:  Melinda A Engevik; Beatrice Herrmann; Wenly Ruan; Amy C Engevik; Kristen A Engevik; Faith Ihekweazu; Zhongcheng Shi; Berkley Luck; Alexandra L Chang-Graham; Magdalena Esparza; Susan Venable; Thomas D Horvath; Sigmund J Haidacher; Kathleen M Hoch; Anthony M Haag; Deborah A Schady; Joseph M Hyser; Jennifer K Spinler; James Versalovic
Journal:  Gut Microbes       Date:  2021 Jan-Dec

9.  Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.

Authors:  Meghan K Eberhardt; W L William Chang; Naomi J Logsdon; Yujuan Yue; Mark R Walter; Peter A Barry
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

10.  Extracellular vesicles modulate host-microbe responses by altering TLR2 activity and phagocytosis.

Authors:  Jeroen van Bergenhenegouwen; Aletta D Kraneveld; Lieke Rutten; Nienke Kettelarij; Johan Garssen; Arjan P Vos
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.